Orchid Pharma: Appoints Arjun Dhanuka as Whole-Time Director
Orchid Pharma Limited announced the appointment of Mr. Arjun Dhanuka as a Whole-Time Director during its Board Meeting on September 03, 2026.…
Ceigall India: Discloses AGM Details and Annual Report Access
Ceigall India Limited has issued a notice regarding its 24th Annual General Meeting (AGM), scheduled for Tuesday, September 29, 2026, at 02:30…
Cohance Lifesciences: Invests $18 Million in NJ Bio and Aruka Bio for ADC Strategy
Cohance Lifesciences Limited is set to strengthen its Antibody-drug Conjugate (ADC) strategy with two proposed transactions: an additional $13…
Cipla: Partners Qilu Pharma for US Biosimilar Launch
Cipla Limited has announced an exclusive partnership with Qilu Pharmaceutical for the licensing and supply of QL2107, a biosimilar to…
Diamond Power Infrastructure: Secures ₹76 Crore EHV Cable Order
Diamond Power Infrastructure Limited (DICABS) has announced the receipt of a Letter of Acceptance for the supply of 66 kV Extra High Voltage…
NHC Foods: Book Closure Announced for 34th AGM
NHC Foods Limited has announced a book closure period from September 19, 2026, to September 25, 2026, inclusive. This closure is for the…
Olatech Solutions: Statutory Auditor Resigns, Cites ‘Professional Commitments’
Olatech Solutions Limited has announced the resignation of its statutory auditor, M/s. Sachin & Associates, Chartered Accountants,…
Newgen Software: CRISIL Reaffirms ‘A1’ Rating on ₹125 Crore Facilities
CRISIL Ratings has reaffirmed the short-term credit rating of CRISIL A1 for Newgen Software Technologies Limited’s debt instruments and…
Canara Bank: Exercises Call Option on Basel III Bonds
Canara Bank has announced its decision to exercise the call option on specific Basel III Compliant Additional Tier I Bonds. The bonds, with…
Parle Industries Limited: Board Approves Director Re-appointment and Auditor Appointment
Parle Industries Limited announced that its Board of Directors, in a meeting held on September 3, 2026, approved several key decisions. These…